Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 2378 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1Comparison between a second and a third generation parathyroid hormone assay in hemodialysis patients
Marie-Hélène Gannagé-Yared,Chirine Farès,Tony Ibrahim,Zeina Abou Rahal,Michele Elias,Dania Chelala
Metabolism.2013;62(10)1416
[DOI]
2Treatment of secondary hyperparathyroidism with paricalcitol in patients with end-stage renal disease undergoing hemodialysis in Turkey: an observational study
Hasan Koc,Hasan Hoser,Yalcin Akdag,Cemaliye Kendir,F. Fevzi Ersoy
International Urology and Nephrology.2019;51(7)1261
[DOI]
3Vitamin D Deficiency—Prognostic Marker or Mortality Risk Factor in End Stage Renal Disease Patients with Diabetes Mellitus Treated with Hemodialysis—A Prospective Multicenter Study
Adalbert Schiller,Florica Gadalean,Oana Schiller,Romulus Timar,Flaviu Bob,Mircea Munteanu,Dana Stoian,Adelina Mihaescu,Bogdan Timar,Antonio Carlos Seguro
PLOS ONE.2015;10(5)e0126586
[DOI]
4Effects of Inactive Vitamin D on Persistent Secondary Hyperparathyroidism in Patients on Hemodialysis
Mojgan Jalalzadeh,Nouraddin Mousavinasab
Nephro-Urology Monthly.2017;9(2)e0126586
[DOI]
5Determining the Levels of Vitamin D and Parathyroid Hormone in Patients on Hemodialysis
R. Mihaylov,B. Pencheva,D. Stoeva,N. Marinova,S. Krivoshiev,G. Michailov
Acta Medica Bulgarica.2016;43(1)23
[DOI]
  Feedback 
  Subscribe 

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal